Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Press Release |
Series Details | EMEA/37589/ 2010 (22.1.10) |
Publication Date | 22/01/2010 |
Content Type | News |
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in January 2010, recommended the granting of a conditional marketing authorisation for a fourth pandemic vaccine, Arepanrix from GlaxoSmithKline Biologicals. |
|
Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000984.jsp&mid=WC0b01ac058004d5c1 |
Related Links |
|
Subject Categories | Health |
Countries / Regions | Europe |